How and Why Medical Affairs Can Support Diversity in Clinical Trials

diversity in clinical trials, role of MSLs, FDA guidance on diversity, patient-centric approaches, cultural awareness and allyship

In this episode, Tom Caravela is joined by Brad Atkinson, Brian Wilson, and Christina Wright to explore the critical role of diversity in clinical trials and the MSL’s part in fostering inclusivity. The discussion covers FDA guidance on diversity, challenges in therapeutic areas, and the …

Aug 24^th • 42 mins listen

Improving Community Clinical Trial Participation

Lack of community participation in cancer clinical trials has long been an issue, as has a lack of diversity among participants. On this CANCER BUZZ mini-podcast, learn about the importance of reaching diverse populations with clinical trials where they live and how one clinical trial has prioriti…

Oct 13^th • 6 mins listen

Advancing Clinical Trial Equity

Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and incl…

Jun 25^th • 8 mins listen

Advanced Practitioners’ Role in Research

In this episode, we'll explore how oncology advanced practitioners (APs) can play a greater role in clinical research and, according to a recent national study, have a strong interest in doing so. Hear how APs can leverage their deep role in the day-to-day cancer care decisions to improve diversit…

Jul 13^th • 6 mins listen

Diversity in Cancer Clinical Trials

“I think it’s important to ensure that you consider each person uniquely. Because no matter how much I know or the nurse knows about the population, everybody is a little bit different. It’s really important to personalize every approach and ask them what they know and meet them …

May 29^th • 27 mins listen